1.Pedersen, BK, Saltin, B. Exercise as medicine–evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25:1-72.
2.Roine, E, Roine, RP, Räsänen, P, et al. Cost-effectiveness of interventions based on physical exercise in the treatment of various diseases: a systematic literature review. Int J Technol Assess Health Care. 2009;25:427-454.
4.Higgins, JP, Altman, DG, Gøtzsche, PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
5.Evers, S, Goossens, M, De Vet, H, Van Tulder, M, Ament, A. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int J Technol Assess Health Care. 2005;21:240-245.
6.Higgins, JP, Green, S, editors. Cochrane handbook for systematic reviews of interventions. Vol. 4. New York: John Wiley & Sons; 2011.
7.Odnoletkova, I, Goderis, G, Pil, L, et al. Cost-effectiveness of therapeutic education to prevent the development and progression of type 2 diabetes. Systematic Review. J Diabetes Metab. 2014;5:438.
8.van Eeden, M, van Heugten, CM, van Mastrigt, GA, Evers, SM. Economic evaluation studies of self-management interventions in chronic diseases: A systematic review. Int J Technol Assess Health Care. 2016;32:16-28.
9.Aboagye, E, Karlsson, ML, Hagberg, J, Jensen, I. Cost-effectiveness of early interventions for non-specific low back pain: A randomized controlled study investigating medical yoga, exercise therapy and self-care advice. J Rehabil Med. 2015;47:167-173.
10.Barton, GR, Sach, TH, Jenkinson, C, et al. Lifestyle interventions for knee pain in overweight and obese adults aged ≥ 45: Economic evaluation of randomised controlled trial. BMJ. 2009;339:b2273.
11.Gusi, N, Tomas-Carus, P. Cost-utility of an 8-month aquatic training for women with fibromyalgia: A randomized controlled trial. Arthritis Res Ther. 2008;10:R24.
12.Henchoz, Y, Pinget, C, Wasserfallen, JB, et al. Cost-utility analysis of a three-month exercise programme vs usual care following multidisciplinary rehabilitation for chronic low back pain. J Rehabil Med. 2010;42:846-852.
13.Hurley, MV, Walsh, NE, Mitchell, HL, et al. Economic evaluation of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain. Arthritis Rheum. 2007;57:1220-1229.
14.Manning, VL, Kaambwa, B, Ratcliffe, J, et al. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: A trial-based analysis. Rheumatology. 2014;54:302-309.
15.Pinto, D, Robertson, MC, Abbott, JH, et al. Manual therapy, exercise therapy, or both, in addition to usual care, for osteoarthritis of the hip or knee. 2: Economic evaluation alongside a randomized controlled trial. Osteoarthritis Cartilage. 2013;21:1504-1513.
16.Sevick, MA, Miller, GD, Loeser, RF, Williamson, JD, Messier, SP. Cost-effectiveness of exercise and diet in overweight and obese adults with knee osteoarthritis. Med Sci Sports Exerc. 2009;41:1167-1174.
17.Tan, SS, van Linschoten, RL, van Middelkoop, M, et al. Cost-utility of exercise therapy in adolescents and young adults suffering from the patellofemoral pain syndrome. Scand J Med Sci Sports. 2010;20:568-579.
18.Tan, SS, Teirlinck, CH, Dekker, J, et al. Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care. Osteoarthritis Cartilage. 2016;24:581-588.
19.Williams, MA, Williamson, EM, Heine, PJ, et al. Strengthening And stretching for Rheumatoid Arthritis of the Hand (SARAH). A randomised controlled trial and economic evaluation. Health Technol Assess. 2015;19:1-222.
20.Hautala, AJ, Kiviniemi, AM, Mäkikallio, T, et al. Economic evaluation of exercise-based cardiac rehabilitation in patients with a recent acute coronary syndrome. Scand J Med Sci Sports. 2017;27:1395-1403.
21.Kühr, EM, Ribeiro, RA, Rohde, LEP, Polanczyk, CA. Cost-effectiveness of supervised exercise therapy in heart failure patients. Value Health. 2011;14:S100-S107.
22.Mazari, FAK, Khan, JA, Carradice, D, et al. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease. Br J Surg. 2013;100:1172-1179.
23.Reed, SD, Whellan, DJ, Li, Y, et al. Economic evaluation of the HF-ACTION randomized controlled trial: An exercise training study of patients with chronic heart failure. Circ Cardiovasc Qual Outcomes. 2010;3:374.
24.Reynolds, MR, Apruzzese, P, Galper, BZ, et al. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: Results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial. J Am Heart Assoc. 2014;3:e001233.
25.Rincón, M, Rojas, MX, Romero, VAR, et al. Economic evaluation of exercise-based cardiac rehabilitation programs for chronic heart failure patients in Colombia. J Cardiopulm Rehabil Prev. 2016;36:12-19.
26.Spronk, S, Bosch, JL, den Hoed, PT, et al. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: A randomized controlled trial. J Vasc Surg. 2008;48:1472-1480.
27.van Asselt, ADI, Nicolaï, SPA, Joore, MA, Prins, MH, Teijink, JAW. Exercise Therapy in Peripheral Arterial Disease Study Group. Cost-effectiveness of exercise therapy in patients with intermittent claudication: Supervised exercise therapy versus a “go home and walk” advice. Eur J Vasc Endovasc Surg. 2011;41:97-103.
28.Van Den Houten, MML, Lauret, GJ, Fakhry, F, et al. Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication. Br J Surg. 2016;103:1616-1625.
29.Witham, MD, Fulton, RL, Greig, CA, et al. Efficacy and cost of an exercise program for functionally impaired older patients with heart failure: A randomized controlled trial. Circ Heart Fail. 2012;5:209-216.
30.Farag, I, Sherrington, C, Hayes, A, et al. Economic evaluation of a falls prevention exercise program among people With Parkinson's disease. Mov Disord. 2016;31:53-61.
31.Fletcher, E, Goodwin, VA, Richards, SH, Campbell, JL, Taylor, RS. An exercise intervention to prevent falls in Parkinson's: An economic evaluation. BMC Health Serv Res. 2012;12:426.
32.McCrone, P, Sharpe, M, Chalder, T, et al. Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: A cost-effectiveness analysis. PLoS One. 2012;7:e40808.
33.Sabes-Figuera, R, McCrone, P, Hurley, M, et al. Cost-effectiveness of counselling, graded-exercise and usual care for chronic fatigue: Evidence from a randomised trial in primary care. BMC Health Serv Res. 2012;12:264.
34.Slaman, J, van den Berg-Emons, R, Tan, SS, et al. Cost-utility of a lifestyle intervention in adolescents and young adults with spastic cerebral palsy. J Rehabil Med. 2015;47:338-345.
35.Tosh, J, Dixon, S, Carter, A, et al. Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: Economic evaluation of a randomised controlled trial. Mult Scler J. 2014;20:1123-1130.
36.d'Amico, F, Rehill, A, Knapp, M, et al. Cost-effectiveness of exercise as a therapy for behavioural and psychological symptoms of dementia within the EVIDEM-E randomised controlled trial. Int J Geriatr Psychiatry. 2016;31:656-665.
37.Edwards, RT, Linck, P, Hounsome, N, et al. Cost-effectiveness of a national exercise referral programme for primary care patients in Wales: Results of a randomised controlled trial. BMC Public Health. 2013;13:1021.
38.Gusi, N, Reyes, MC, Gonzalez-Guerrero, JL, Herrera, E, Garcia, JM. Cost-utility of a walking programme for moderately depressed, obese, or overweight elderly women in primary care: A randomised controlled trial. BMC Public Health. 2008;8:231.
39.Gordon, LG, DiSipio, T, Battistutta, D, et al. Cost-effectiveness of a pragmatic exercise intervention for women with breast cancer: Results from a randomized controlled trial. Psychooncology. 2017;26:649-655.
40.Mewes, JC, Steuten, LMG, Duijts, SFA, et al. Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients. J Cancer Surviv. 2015;9:126-135.
41.Retèl, VP, van der Molen, L, Hilgers, FJ, et al. A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy. BMC Cancer. 2011;11:475.
42.Panman, CM, Wiegersma, M, Kollen, BJ, et al. Two-year effects and cost-effectiveness of pelvic floor muscle training in mild pelvic organ prolapse: A randomised controlled trial in primary care. BJOG. 2017;124:511-520.
43.Panman, CM, Wiegersma, M, Kollen, BJ, et al. Effectiveness and cost-effectiveness of pessary treatment compared with pelvic floor muscle training in older women with pelvic organ prolapse: 2-year follow-up of a randomized controlled trial in primary care. Menopause. 2016;23:1307-1318.
44.Zwerink, M, Effing, T, Kerstjens, HAM, et al. Cost-effectiveness of a community-based exercise programme in COPD self-management. COPD. 2016;13:214-223.
45.Coyle, D, Coyle, K, Kenny, GP, et al. Cost-effectiveness of exercise programs in type 2 diabetes. Int J Technol Assess Health Care. 2012;28:228-234.